Mallinckrodt (MNK) Announces Agreement in Principle for Global Opioid Settlement and Associated Debt Refinancing Activities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Teva (TEVA), Endo (ENDP) Trade Higher in Sympathy with Mallinckrodt (MNK) Following Opioid Settlement Agreement
February 25, 2020 8:22 AM ESTTeva (NYSE: TEVA), Endo (NASDAQ: ENDP) Trade Higher in Sympathy with Mallinckrodt (NYSE: MNK) Following Opioid Settlement Agreement
... MoreMallinckrodt (MNK) Tops Q4 EPS by 35c
February 25, 2020 6:13 AM ESTMallinckrodt (NYSE: MNK) reported Q4 EPS of $2.40, $0.35 better than the analyst estimate of $2.05. Revenue for the quarter came in at $804.9 million versus the consensus estimate of $772.52 million.
As separately announced today, reached an agreement in principle for a global settlement with a... MoreMallinckrodt proposes $1.6 billion opioid deal, Chapter 11 for generics unit: WSJ
February 24, 2020 2:48 PM EST(Reuters) - Mallinckrodt Plc (NYSE: MNK) is finalizing a settlement proposal of at least $1.6 billion that would place its U.S. generic drug business into bankruptcy to address the debt maturities and liabilities arising out of the opioid crisis, the Wall Street Journal reported on Monday.
The proposed deal includes a Chapter 11 filing covering the generics unit and a... More
Teva (TEVA), Endo (ENDP) Weakness Tied to Mallinckrodt (MNK) Bankruptcy Report
February 24, 2020 2:40 PM ESTWeakness in Teva Pharma (NYSE: TEVA) and Endo International (NASDAQ: ENDP) Monday afternoon was said to be tied in part to rumors peer Mallinckrodt (NYSE: MNK) is in creditor talks ahead of a potential bankruptcy of its U.S. generics business.
... More